Dr. Harish Kancharla

Dr. Harish Kancharla is a Consultant Medical Oncologist and Hemato-Oncologist at Yashoda Hospitals in Hyderabad, India, with over 14 years of clinical experience in comprehensive cancer care. He holds a DM in Medical Oncology from AIIMS Delhi (where he secured All India 1st Rank in the DM/MCh Entrance Examination) and an MD in Internal Medicine from PGIMER Chandigarh, alongside his MBBS from Gandhi Medical College, Hyderabad. His training at India's premier medical institutions has established him as a trusted authority in oncology.

Dr. Kancharla's clinical expertise spans the full spectrum of solid tumours and haematological malignancies, with particular depth in gastrointestinal cancers, head and neck malignancies, urogenital cancers, breast cancer, thoracic oncology, sarcomas, and leukaemias. He is proficient in modern treatment modalities including conventional chemotherapy, cancer immunotherapy, targeted molecular therapy, hormone therapy, and bone marrow transplantation. His approach integrates evidence-based protocols with individualised patient management, and he regularly presents his clinical outcomes and research findings at national and international oncology conferences.

Dr. Kancharla has built a strong reputation for treating international patients from across the Gulf region, Africa, and South Asia. He is fluent in English, Hindi, and Telugu, ensuring clear communication with diverse patient populations. His consultations are supported by Gaf Healthcare's comprehensive patient coordination services, including medical document review, video conferencing, and seamless care transition. Patients appreciate his patient-centred approach, clinical thoroughness, and commitment to explaining complex treatment options in accessible language.

Yashoda Hospitals, where Dr. Kancharla practices, is a leading multispecialty tertiary care institution recognised for its oncology division, advanced diagnostics, and international patient services. The hospital combines modern infrastructure with a collaborative care model, ensuring patients receive coordinated support from surgery, radiation, and medical oncology teams. For international patients seeking specialist cancer care in India, Yashoda Hospitals provides a trusted destination with NABH accreditation, dedicated international patient facilitation, and transparent treatment pathways.

Dr. Kancharla is an active member of the European Society for Medical Oncology (ESMO), the International Association for the Study of Lung Cancer (IASLC), and the Indian Cooperative Oncology Network (ICON), reflecting his commitment to maintaining global best practice standards. International patients can confidently engage with Dr. Kancharla knowing they will receive world-standard oncology care delivered in a welcoming, English-speaking environment with full support for travel, accommodation, and post-treatment follow-up.